Financiado en parte por AlzChem AG (Germany)
Effects of long-term low-dose dietary creatine supplementation in older women
Lobo DM, Tritto AC, da Silva LR, de Oliveira PB, Benatti FB, Roschel H, Nieß B, Gualano B, Pereira RM
Experimental gerontology · 47 citas
Etiquetas de revisión
Financiado por la industriaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiado por la industria
- Gobierno
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Gobierno
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Gobierno
- Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)
- Gobierno
- CAPES
- Empresa
- AlzChem AG (Germany)
Según 5 financiadores declarados.
Publicación
- Publicado
- 2015-07-17 · Exp Gerontol · vol. 70 · págs. 97–104
- Editorial
- Elsevier BV
- Citado
- 66 citas · más que el 81% de estudios similares · 1.6× el promedio de su campo
- Referencias
- 45 trabajos
- Acceso
- Acceso abierto (revista híbrida) · CC-BY-NC-ND
- Áreas de investigación
- Muscle metabolism and nutrition · Nutrition and Health in Aging · Cardiovascular and exercise physiology
- Palabras clave
- Creatine, Medicine, Lean body mass, Adverse effect, Placebo, Creatine Monohydrate, Bone mineral, Osteoporosis, Randomized controlled trial, Femoral neck, Internal medicine, Osteopenia, Bone density, Body mass index, Physical therapy, Physiology, Body weight
- MeSH
- muscle, skeletal, humans, bone diseases, metabolic, creatine, absorptiometry, photon, double-blind method, bone remodeling, body composition, bone density, dose-response relationship, drug, dietary supplements, aged, middle aged, female, biomarkers
9 autores
- Daniel Medeiros Lobo🇧🇷Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Aline C. Tritto🇧🇷Universidade de São Paulo
- Luana Rodrigues da Silva🇧🇷Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Paloma Borges de Oliveira🇧🇷Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Fabiana Braga Benatti🇧🇷Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Hamilton Roschel🇧🇷Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Barbara Nieß🇩🇪AlzChem (Germany)
- Bruno Gualano🇧🇷Universidade de São Paulo; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Rosa Maria Rodrigues Pereira🇧🇷Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Resumen
El texto original del estudio, en el idioma en que se publicó.
Objective
We aimed to investigate the effects of a one-year low-dose creatine supplementation trial on bone health, lean mass, and muscle function in older postmenopausal women.
Methods
A double-blind, randomized, parallel-group, placebo controlled trial was conducted between November 2011 and November 2013 in Sao Paulo, Brazil. Postmenopausal osteopenic women were randomly allocated (1:1) into creatine (n=56; 1g/d) or placebo group (n=53; dextrose at same dose). At baseline and after one year of intervention, we assessed parameters of bone health, body composition, and muscle function. Blood parameters were also assessed before and after the intervention and adverse events were recorded throughout the trial. Possible differences in dietary intake were assessed by three 24-h dietary recalls.
Results
Bone mineral density at lumbar spine, femoral neck, total femur, and whole body did not differ within- or between-groups. No significant changes in body weight, BMI, absolute and relative body fat, and body lean mass were observed. Muscle function, as assessed by timed-up-and-go and timed-stands tests, were not significantly changed within- or between-groups. Safety laboratory parameters remained unaltered.
Conclusion
A one-year low-dose creatine supplementation (1g/d) was free of adverse effects, but did not affect bone health parameters, lean mass, or muscle function in older women. Further studies with longer follow-up periods and higher doses of creatine supplementation are warranted. (Registered at clinicaltrials.gov as NCT01472393).
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.